BioCentury
ARTICLE | Company News

ObeSys Ltd., Cambridge Antibody Technology Ltd. deal

January 2, 1996 8:00 AM UTC

ObeSys entered into a strategic alliance with Cambridge Antibody Technology for the discovery and development of an anti-obesity drug. Cambridge Antibody will use its antibody screening technology to ...